Copyright
©2014 Baishideng Publishing Group Inc.
World J Radiol. Oct 28, 2014; 6(10): 741-755
Published online Oct 28, 2014. doi: 10.4329/wjr.v6.i10.741
Published online Oct 28, 2014. doi: 10.4329/wjr.v6.i10.741
Figure 11 Effective dose vs patient weight for 2-deoxy-2-(18F)fluoro-D-glucose (European Association of Nuclear Medicine and North American Consensus Guidelines).
Image courtesy of Bruce McBride, Chief Physicist, Department of Nuclear Medicine and PET, The Prince of Wales and Sydney Children’s Hospitals. PET: Positron emission tomography; EANM: European Association of Nuclear Medicine.
- Citation: Freebody J, Wegner EA, Rossleigh MA. 2-deoxy-2-(18F)fluoro-D-glucose positron emission tomography/computed tomography imaging in paediatric oncology. World J Radiol 2014; 6(10): 741-755
- URL: https://www.wjgnet.com/1949-8470/full/v6/i10/741.htm
- DOI: https://dx.doi.org/10.4329/wjr.v6.i10.741